Connance

Canaccord Genuity acts as exclusive financial advisor to Connance on its sale to Waystar Health  

Canaccord Genuity is pleased to announce that on September 17, 2018, Connance completed its sale to Waystar Health. Terms of this transaction were not disclosed.

Connance is a healthcare technology company providing health systems and BPOs a predictive analytics platform to optimize workflow by utilizing non-clinical information to predict certain patient response outcomes. With its back-end revenue cycle management capabilities, Connance offers solutions in patient pay optimization, vendor management and reimbursement management. The Company’s proprietary data asset now includes more than 100 million unique patients, adding more than 3 million new patient encounters each month.

Waystar is the combination of Navicure and ZirMed, two top-rated providers of revenue cycle technologies. Waystar simplifies and unifies the healthcare revenue cycle with innovative technology that allows clients to collect more with less cost and less stress, so they can focus on their goals, patients and communities.  The Waystar platform supports more than 400,000 providers, hospitals, health systems and ambulatory services organizations and partners with the leading EHR and practice management solution providers

Canaccord Genuity served as exclusive advisor to Connance.